Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Mononuclear cells from peripheral blood or bone marrow from 314 patients with acute myeloid leukaemia were examined for the presence of nuclear terminal deoxynucleotidyl transferase (304 patients), surface membrane expression of HLA-DR (314 patients) and the common acute lymphoblastic leukaemia antigen (281 patients). All patients were treated with identical remission induction chemotherapy, and morphological diagnosis was carried out in a central laboratory. The overall complete remission rate was 70%. There were no significant correlations between the immunological markers and complete remission rate, duration of remission, or survival.


Journal article


Br J Haematol

Publication Date





193 - 198


Adolescent, Adult, Aged, Aged, 80 and over, Antigens, Differentiation, Antigens, Neoplasm, Antigens, Surface, Child, Child, Preschool, DNA Nucleotidylexotransferase, HLA-DR Antigens, Humans, Infant, Infant, Newborn, Leukemia, Myeloid, Acute, Middle Aged, Neprilysin, Prognosis